Glucocorticoid-induced tumor necrosis factor (TNF) receptor related gene or “GITR,” also known as TNF receptor superfamily member 18 (TNFRSF18), was listed by the National Cancer Institute as among the most promising immunotherapy agents for cancer [1]. This evidence concerns the gene TNFRSF18 and cancer.